MCRB vs BYSI
Comparison between Seres Therapeutics Inc (MCRB, Company) and BeyondSpring Inc (BYSI, Company).
Both MCRB and BYSI are from the Healthcare sector.
5-Year PerformanceBYSI has outperformed MCRB, delivering a return of -34.2% compared to -58.3%
MCRB vs BYSI - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
MCRB vs BYSI - Historical Returns
Returns include dividend reinvestment.
MCRB vs BYSI - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | MCRB | BYSI |
|---|---|---|
| 2026 | -65.35% | -22.36% |
| 2025 | -11.78% | +2.52% |
| 2024 | -40.64% | +90.42% |
| 2023 | -74.07% | -48.57% |
| 2022 | -36.65% | -62.48% |
| 2021 | -66.76% | -62.75% |
| 2020 | +631.34% | -21.29% |
| 2019 | -28.57% | -16.40% |
| 2018 | -57.16% | -35.34% |
| 2017 | +1.30% | +73.09% |
| 2016 | -70.97% | N/A |
| 2015 | -31.73% | N/A |
MCRB vs BYSI Drawdown Comparison
The maximum drawdown for MCRB was -99.50%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The maximum drawdown for BYSI was -98.83%, occurring on Dec 8, 2022. This drawdown has not yet recovered.
The current MCRB drawdown is -99.49%. The current BYSI drawdown is -97.41%.
| Rank | MCRB | BYSI |
|---|---|---|
| #1 | -99.50% Jun 26, 2015 - Jul 20, 2026 | -98.83% Jul 3, 2017 - Dec 8, 2022 |
| #2 | N/A | -31.39% Jun 6, 2017 - Jul 3, 2017 |
| #3 | N/A | -6.91% Mar 13, 2017 - Mar 17, 2017 |
| #4 | N/A | -6.57% Mar 17, 2017 - Mar 31, 2017 |
| #5 | N/A | -4.33% May 4, 2017 - May 16, 2017 |
| #6 | N/A | -1.97% May 16, 2017 - May 18, 2017 |
| #7 | N/A | -1.44% Apr 27, 2017 - May 2, 2017 |
| #8 | N/A | -0.85% Mar 31, 2017 - Apr 7, 2017 |
| #9 | N/A | -0.75% Apr 7, 2017 - Apr 13, 2017 |
| #10 | N/A | -0.60% Apr 21, 2017 - Apr 26, 2017 |
| #11 | N/A | -0.51% Apr 19, 2017 - Apr 21, 2017 |
| #12 | N/A | -0.39% May 25, 2017 - May 30, 2017 |
Correlation
Correlation between MCRB and BYSI is 0.41 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks